Last reviewed · How we verify

S5G4T-2

Sol-Gel Technologies, Ltd. · Phase 3 active Small molecule

S5G4T-2 is a topical gel formulation of a retinoid, which works by modulating the activity of retinoic acid receptors in the skin.

S5G4T-2 is a topical gel formulation of a retinoid, which works by modulating the activity of retinoic acid receptors in the skin. Used for Acne vulgaris.

At a glance

Generic nameS5G4T-2
Also known asVehicle cream
SponsorSol-Gel Technologies, Ltd.
Drug classRetinoid
TargetRetinoic acid receptors
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

By activating these receptors, S5G4T-2 helps to regulate the growth and differentiation of skin cells, leading to improved symptoms of acne and other skin conditions. This mechanism of action is similar to other retinoid-based treatments, but the topical gel formulation of S5G4T-2 allows for more targeted delivery and potentially reduced systemic side effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results